OraSure Seeks Panel Feedback On Marketing Of Home-Use HIV Test

OraSure Technologies will seek guidance from FDA's Blood Product's Advisory Committee on making its OraQuick Advance oral HIV test available over the counter for use in the home

More from Archive

More from Medtech Insight